Intervacc AB (publ) (STO:IVACC)
Sweden · Delayed Price · Currency is SEK 1.242
+0.020 (1.64%)
Jul 24, 2026, 4:40 PM CET
Intervacc AB Employees
Intervacc AB had 16 employees as of December 31, 2025. The number of employees increased by 1 or 6.67% compared to the previous year.
Employees
16
Change
1
Growth
6.67%
Revenue / Employee
1.18M SEK
Profits / Employee
-5.59M SEK
Market Cap
416.47M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 16 | 1 | 6.67% |
| Dec 31, 2023 | 15 | 0 | - |
| Dec 31, 2022 | 15 | 2 | 15.38% |
| Dec 31, 2021 | 13 | 1 | 8.33% |
| Dec 31, 2020 | 12 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Oncopeptides AB | 77 |
| Sprint Bioscience AB | 30 |
| Xbrane Biopharma AB | 29 |
| Xspray Pharma AB | 24 |
| Cantargia AB | 22 |
| Mendus AB | 19 |
| Corline Biomedical AB | 13 |
| AlzeCure Pharma AB | 10 |
Intervacc AB News
- 2 months ago - Intervacc AB Quarterly report: Q1 2026 - Filings
- 2 months ago - Intervacc AB (OSTO:IVACC) Q1 2026: Everything You Need to Know Ahead of Earnings - GuruFocus
- 4 months ago - Intervacc AB Slides: FY 2026 - Filings
- 5 months ago - Intervacc AB Quarterly report: Q4 2025 - Filings
- 5 months ago - Intervacc AB Annual report: Q4 2025 - Filings
- 5 months ago - Earnings To Watch: Intervacc AB (OSTO:IVACC) Reports Q4 2025 Result - GuruFocus
- 8 months ago - Intervacc AB Transcript: DNB Carnegie Småbolagsdag - Transcripts
- 8 months ago - Intervacc AB Quarterly report: Q3 2025 - Filings